Today March 28 the Swedish market close at 13.00. Danish and Norweigan markets is closed.

NextCell Pharma operates in medical technology. Today, development is carried out of stem cell products mainly used in the treatment of autoimmune diabetes and for kidney transplants. A significant part of the work consists of stem cell research where the company develops drug candidates that should enable and increase the acceptance of organ transplants. In addition, the company has a stem cell bank. The company was established in 2014 and is based in Huddinge.

Quotes for NextCell Pharma AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Mathias Svahn

Chairperson of the Board

  • Anders Essen-Möller

Board

  • Camilla Myhre Sandberg
  • Edvard Smith
  • Hans-Peter Ekre
  • Niclas Löwgren

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 14,49 14,49 2023-12-27
Diamyd Medical AB 12,46 12,46 2023-12-27
Anders Essen-Möller 3,24 3,24 2023-12-27
Mabtech Group AB 2,46 2,46 2023-12-27
Nordnet Pensionsförsäkring 2,17 2,17 2023-12-27
Konstruktions o Försäljnings AB KFAB 1,89 1,89 2023-12-27
Nordea Liv & Pension 1,77 1,77 2023-12-27
Robert Joki 1,64 1,64 2023-12-27
Filip Wirefors 1,24 1,24 2023-12-27
Bioall AB 1,13 1,13 2023-12-27